KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unitedhealth (UNH) Depreciation & Amortization (CF) (2016 - 2025)

Unitedhealth (UNH) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 7.3% to $1.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.4 billion, a 6.39% increase, with the full-year FY2025 number at $4.4 billion, up 6.39% from a year prior.
  • Depreciation & Amortization (CF) was $1.1 billion for Q4 2025 at Unitedhealth, up from $1.1 billion in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.1 billion in Q4 2025 to a low of $758.0 million in Q1 2021.
  • A 5-year average of $956.0 million and a median of $997.0 million in 2024 define the central range for Depreciation & Amortization (CF).
  • Biggest YoY gain for Depreciation & Amortization (CF) was 27.31% in 2023; the steepest drop was 0.81% in 2023.
  • Unitedhealth's Depreciation & Amortization (CF) stood at $796.0 million in 2021, then increased by 23.37% to $982.0 million in 2022, then dropped by 0.81% to $974.0 million in 2023, then increased by 6.88% to $1.0 billion in 2024, then grew by 7.3% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for UNH's Depreciation & Amortization (CF) are $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025).